Correction to: Respir Res (2020) 21:134 https://doi.org/10.1186/s12931-020-01387-z
The original version of the article unfortunately contained a mistake in the disclosure statement.
It has been corrected in this correction.
It should read as,
Disclosure section
The disclosure statement was incomplete, the correct statement is “MeiLan K Han received writing and research support from GlaxoSmithKline for this work. Outside this work, she also reports personal fees from GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Merck and Mylan. She also reports research support from Novartis and Sunovion.”
Reference
Singh D, Criner GJ, Naya I, Jones PW, Tombs L, Lipson DA, Han MK. Measuring disease activity in COPD: is clinically important deterioration the answer? Respir Res. 2020;21:134.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Singh, D., Criner, G.J., Naya, I. et al. Correction to: Measuring disease activity in COPD: is clinically important deterioration the answer?. Respir Res 22, 299 (2021). https://doi.org/10.1186/s12931-021-01894-7
Published:
DOI: https://doi.org/10.1186/s12931-021-01894-7